Related Experiment Videos
B cells regulate autoimmunity by provision of IL-10
Simon Fillatreau1, Claire H Sweenie, Mandy J McGeachy
1University of Edinburgh, Institute of Cell, Animal and Population Biology, King's Buildings West Mains Road, Edinburgh EH9 3JT, UK.
Nature Immunology
|September 24, 2002
Summary
B cells are crucial for controlling autoimmune diseases like experimental autoimmune encephalomyelitis. Autoantigen-reactive B cells produce interleukin 10 (IL-10), which is essential for immune system recovery and preventing persistent inflammation.
Area of Science:
- Immunology
- Autoimmunity
- Cellular Biology
Background:
- T helper type 1 (T(H)1) immune responses drive experimental autoimmune encephalomyelitis (EAE).
- The role of B cell regulation in T cell differentiation and autoimmune disease resolution is not fully understood.
Purpose of the Study:
- To investigate the significance of B cell-mediated control over T cell differentiation in EAE.
- To determine the role of B cell-derived cytokines in the recovery from autoimmune disease.
Main Methods:
- Analysis of EAE course in mice with modified B cell compartments.
- Utilizing a bone marrow chimeric system to create mice with B cell-specific IL-10 deficiency.
- Assessing autoantigen-specific B cell responses and cytokine production (IL-10).
Main Results:
- Recovery from EAE was contingent upon the presence of autoantigen-reactive B cells.
- B cells from recovered mice produced interleukin 10 (IL-10) upon autoantigen stimulation.
- Mice lacking B cell-derived IL-10 exhibited persistent pro-inflammatory type 1 immune responses and failed to recover from EAE.
Conclusions:
- B cell-derived IL-10 is a critical factor in suppressing T(H)1-driven autoimmunity.
- Targeting B cell IL-10 production represents a potential therapeutic strategy for autoimmune diseases.